Virtual Eating Disorder Treatment Market By Type (Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder (BED), Other Types) By Treatment (Partial hospitalization programs (PHP), Intensive day programs (IDP), Intensive outpatient programs (IOP), Outpatient sessions, Group Therapy, Other treatments) By Distribution Channels (Hospitals, Clinics, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: June 2024
Report ID: 73120
Number of Pages: 359
Format:

Fact Checked

Cite this Research

- 1.Virtual Eating Disorder Treatment Market Introduction
  - 1.1.Definition
  - 1.2.Taxonomy
  - 1.3.Research Scope
- 2.Executive Summary
  - 2.1.Key Findings by Major Segments
  - 2.2.Top strategies by Major Players
- 3.Global Virtual Eating Disorder Treatment Market Overview
  - 3.1.Virtual Eating Disorder Treatment Market Dynamics
    
    3.1.1.Drivers
    
    3.1.2.Opportunities
    
    3.1.3.Restraints
    
    3.1.4.Challenges
  - 3.2.COVID-19 Impact Analysis
  - 3.3.COVID-19 Impact Analysis in Global Virtual Eating Disorder Treatment Market
  - 3.4.PESTLE Analysis
  - 3.5.Opportunity Map Analysis
  - 3.6.PORTER'S Five Forces Analysis
  - 3.7.Market Competition Scenario Analysis
  - 3.8.Product Life Cycle Analysis
  - 3.9.Opportunity Orbits
  - 3.10.Manufacturer Intensity Map
  - 3.11.Major Companies sales by Value & Volume
- 4.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2015-2031
  - 4.1.Global Virtual Eating Disorder Treatment Market Analysis by Type: Introduction
  - 4.2.Market Size and Forecast by Region
  - 4.3.Anorexia Nervosa
  - 4.4.Bulimia Nervosa
  - 4.5.Binge Eating Disorder (BED)
  - 4.6.Other Types
- 5.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Patient, 2015-2031
  - 5.1.Global Virtual Eating Disorder Treatment Market Analysis by Patient: Introduction
  - 5.2.Market Size and Forecast by Region
  - 5.3.Inpatients
  - 5.4.Outpatients
- 6.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Treatment, 2015-2031
  - 6.1.Global Virtual Eating Disorder Treatment Market Analysis by Treatment: Introduction
  - 6.2.Market Size and Forecast by Region
  - 6.3.Medications
  - 6.4.Therapy
  - 6.5.Other Treatments
- 7.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2015-2031
  - 7.1.Global Virtual Eating Disorder Treatment Market Analysis by End-User: Introduction
  - 7.2.Market Size and Forecast by Region
  - 7.3.Hospitals
  - 7.4.Clinics
  - 7.5.Other End Users
- 8.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Route of Administration, 2015-2031
  - 8.1.Global Virtual Eating Disorder Treatment Market Analysis by Route of Administration: Introduction
  - 8.2.Market Size and Forecast by Region
  - 8.3.Oral
  - 8.4.Parenteral
  - 8.5.Other Route of Administrations
- 9.Global Virtual Eating Disorder Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2015-2031
  - 9.1.North America
    
    9.1.1.North America Virtual Eating Disorder Treatment Market: Regional Trend Analysis
    
    9.1.1.1.U.S.
    
    9.1.1.2.Canada
    
    9.1.1.3.Mexico
  - 9.2.1.Europe
    
    9.2.1.Europe Virtual Eating Disorder Treatment Market: Regional Trend Analysis
    
    9.2.1.1.U.K.
    
    9.2.1.2.Germany
    
    9.2.1.3.France
    
    9.2.1.4.Spain
    
    9.2.1.5.Italy
    
    9.2.1.6.Russia
    
    9.2.1.7.Rest of Europe
  - 9.3.Asia-Pacific
    
    9.3.1.Asia-Pacific Virtual Eating Disorder Treatment Market: Regional Trend Analysis
    
    9.3.1.1.China
    
    9.3.1.2.Japan
    
    9.3.1.3.South Korea
    
    9.3.1.4.India
    
    9.3.1.5.ASEAN
    
    9.3.1.6.Rest of Asia-Pacific
  - 9.4.Latin America
    
    9.4.1.Latin America Virtual Eating Disorder Treatment Market: Regional Trend Analysis
    
    9.4.1.1.Brazil
    
    9.4.1.2.Argentina
    
    9.4.1.3.Rest of Latin America
  - 9.5.Middle East and Africa
    
    9.5.1.Middle East and Africa Virtual Eating Disorder Treatment Market: Regional Trend Analysis
    
    9.5.1.1.GCC
    
    9.5.1.2.Israel
    
    9.5.1.3.South Africa
    
    9.5.1.4.Rest of MEA
- 10.Global Virtual Eating Disorder Treatment Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 10.1.Market Share Analysis
  - 10.2.Company Profiles
  - 10.3.The Renfrew Center
    
    10.3.1.Company Overview
    
    10.3.2.Financial Highlights
    
    10.3.3.Product Portfolio
    
    10.3.4.SWOT Analysis
    
    10.3.5.Key Strategies and Developments
  - 10.4.Alsana West LLC
    
    10.4.1.Company Overview
    
    10.4.2.Financial Highlights
    
    10.4.3.Product Portfolio
    
    10.4.4.SWOT Analysis
    
    10.4.5.Key Strategies and Developments
  - 10.5.Bausch & Lomb Incorporated
    
    10.5.1.Company Overview
    
    10.5.2.Financial Highlights
    
    10.5.3.Product Portfolio
    
    10.5.4.SWOT Analysis
    
    10.5.5.Key Strategies and Developments
  - 10.6.Apotex Inc.
    
    10.6.1.Company Overview
    
    10.6.2.Financial Highlights
    
    10.6.3.Product Portfolio
    
    10.6.4.SWOT Analysis
    
    10.6.5.Key Strategies and Developments
  - 10.7.Somerset Therapeutics LLC
    
    10.7.1.Company Overview
    
    10.7.2.Financial Highlights
    
    10.7.3.Product Portfolio
    
    10.7.4.SWOT Analysis
    
    10.7.5.Key Strategies and Developments
  - 10.8.Mylan N.V
    
    10.8.1.Company Overview
    
    10.8.2.Financial Highlights
    
    10.8.3.Product Portfolio
    
    10.8.4.SWOT Analysis
    
    10.8.5.Key Strategies and Developments
  - 10.9.Teva Pharmaceuticals Industries Ltd.
    
    10.9.1.Company Overview
    
    10.9.2.Financial Highlights
    
    10.9.3.Product Portfolio
    
    10.9.4.SWOT Analysis
    
    10.9.5.Key Strategies and Developments
  - 10.10.Pfizer Inc.
    
    10.10.1.Company Overview
    
    10.10.2.Financial Highlights
    
    10.10.3.Product Portfolio
    
    10.10.4.SWOT Analysis
    
    10.10.5.Key Strategies and Developments
  - 10.11.Sun Pharmaceutical Industries Ltd.
    
    10.11.1.Company Overview
    
    10.11.2.Financial Highlights
    
    10.11.3.Product Portfolio
    
    10.11.4.SWOT Analysis
    
    10.11.5.Key Strategies and Developments
  - 10.12.Amneal Pharmaceutical Inc.
    
    10.12.1.Company Overview
    
    10.12.2.Financial Highlights
    
    10.12.3.Product Portfolio
    
    10.12.4.SWOT Analysis
    
    10.12.5.Key Strategies and Developments
  - 10.13.Eli Lilly and Company
    
    10.13.1.Company Overview
    
    10.13.2.Financial Highlights
    
    10.13.3.Product Portfolio
    
    10.13.4.SWOT Analysis
    
    10.13.5.Key Strategies and Developments
  - 10.14.AbbVie Inc.
    
    10.14.1.Company Overview
    
    10.14.2.Financial Highlights
    
    10.14.3.Product Portfolio
    
    10.14.4.SWOT Analysis
    
    10.14.5.Key Strategies and Developments
  - 10.15.GlaxoSmithKline Plc
    
    10.15.1.Company Overview
    
    10.15.2.Financial Highlights
    
    10.15.3.Product Portfolio
    
    10.15.4.SWOT Analysis
    
    10.15.5.Key Strategies and Developments
- 11.Assumptions and Acronyms
- 12.Research Methodology
- 13.Contact
- The Renfrew Center
- Alsana, Inc.
- AbbVie Inc.
- Equip Health
- ARISE HEALTH INC
- Eli Lilly and Company
- Pfizer Inc.
- Monte Nido & Affiliates
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd.
- GlaxoSmithKline Plc
- Other Key Players